January 2020

As we reported in October, the Centers for Medicare and Medicaid Services (“CMS”) and the Department of Health and Human Services…

Paul Mathieu, MD, of New Jersey, was recently sentenced to four years in prison for his role in a scheme to defraud Medicare and…

On January 23, 2020, the CME Coalition held a webinar on the proposed changes to the ACCME Standards for Commercial Support, which…

Oklahoma Attorney General Mike Hunter recently announced an $8.75 million settlement with Endo Pharmaceuticals, Inc. for the…

The Centers for Medicare and Medicaid Services (“CMS”) released the final 2018 performance data for its Quality Payment Program…

A recent study by Rockpointe demonstrated the value of CME for atrial fibrillation (AFib) patients and the physicians who treat…

By Dr. Seth B. Whitelaw As predicted, the epidemic of opioid-related lawsuits continues to pick-up steam with the State of…

The US Food and Drug Administration (FDA) proposed revisions to its medical device regulations to end the practice of publishing…

The US Food and Drug Administration (FDA) issued draft guidance on demonstrating “substantial evidence” of effectiveness for drugs…

In an opinion filed on December 16, 2019, and published by the American Hospital Association (AHA), U.S. District Judge Rosemary…